Seeking strategic M&A or technology out-licensing opportunities ● Intradermal Platform provides easy access to skin for both biosensing and therapeutic or cosmetic drug delivery ● Completed in vivo studies to… Read More
June 16, 2020, Vancouver, Canada: Alpha-9 Theranostics Inc, a radiopharmaceutical company developing unique technology for imaging and treatment of metastatic cancer, today announced that the first patient in a Phase… Read More
VANCOUVER, BC, June 11, 2020 /PRNewswire/ — Bold Therapeutics, a clinical-stage biopharmaceutical company, has expanded its COVID-19 collaborations to include four more academic researchers: François Jean, PhD and Ted Steiner, MD, both researchers from the University… Read More
SEATTLE, June 15, 2020 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced it will host a virtual Investor R&D Showcase… Read More
Combination creates a diversified biopharmaceutical company with a robust product pipeline targeting rare, unmet medical needs in oncology Pipeline led by two late-stage, Phase 3-ready cancer therapeutics – VAL-083 for… Read More
